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Emad A Rakha, Bernard Chi-Shern Ho, Veena K Naik, Soumadri Sen, Lisa Hamilton, et al. (1998) (1999) (2000) . The proportion of B3 diagnoses increased from 3.1% to 4.5% and the positive predictive value (PPV) of malignancy of a B3 core decreased from 25% to 10%. Increased diagnosis of radial scar and reductions in the PPV of lobular neoplasia and of atypical intraductal proliferation may explain the reduction in the PPV of the B3 group as a whole. There were no significant changes in the proportion of B4 diagnosis (1.1% and 0.8%) or the PPV of B4 (83% and 88%). Review of cores with intraductal atypia showed a wide range of PPVs from 100% for suspicious of DCIS, to 40% for atypical ductal hyperplasia categorised as B3, and 14% for isolated flat epithelial atypia.
Conclusion:
The study has found a decrease in the PPV for a B3 diagnosis and suggests possible explanations. 
INTRODUCTION
Needle core biopsy (NCB) is now considered as the method of choice for the triple assessment of breast lesions 1 and the published data suggest that the use of core biopsy has significantly increased the preoperative diagnosis rate. [2] [3] [4] The majority of NCB are classified as normal (B1), benign (B2) or malignant (B5). 5 The accuracy of benign and malignant NCB diagnoses is supported by the use of two borderline categories: lesion of uncertain malignant potential (B3) and suspicious of malignancy (B4). The B3 category consists of a heterogeneous group of lesions, which for sampling or other reasons may yield only benign histology on initial NCB sampling but are recognised to show heterogeneity and may harbour malignancy elsewhere or to have an increased risk of associated adjacent malignancy. 2, 5, 6 The B4 category is most commonly used for small fragments of atypical cells separate from the main core, focal atypical intraductal proliferations, which are insufficient for confident diagnosis of DCIS or very small foci of invasive carcinoma in which there is insufficient material for a definite diagnosis. 5, 7 Although the B3 and B4 categories constitute a relatively small proportion of all NCB, 2, 7-9 most cases progress to surgical intervention to establish an excision histology diagnosis.
In a previous study of NCB in the screening setting, we found that the performance of NCB improved over time since its introduction, 2 which may reflect an improvement in the radiological evaluation of breast lesions, sampling technique, 10, 11 publishing of guidelines for assessing breast lesions and reporting of NCB. 5 We also noted a reduction in the positive predictive . 7 In addition, sections showing intraductal epithelial atypia were reviewed to assess the outcome of the different subtypes of atypia.
MATERIALS AND METHODS
All NCBs reported as B3 or B4 in the 2-year period from January 2007 to December 2008 were studied. NCB results were categorised according to UK guidelines. 5 All patients with a core biopsy diagnosis are discussed at a multidisciplinary meeting, with a breast radiologist, histopathologist and surgeon present, at which decisions on further action are made. Those patients not undergoing an excision biopsy were therefore subject to multidisciplinary discussion to ensure that this conclusion was appropriate.
Histology reports of B3 and B4 NCB and the subsequent diagnostic surgical biopsy results of all patients were reviewed. For the purpose of this study, excision histology findings were categorised as a) malignant including invasive carcinoma, ductal carcinoma in situ (DCIS), and other malignant lesions such as sarcomas and lymphomas, and b) benign lesions including atypical ductal hyperplasia (ADH), classical lobular neoplasia (atypical lobular hyperplasia and lobular carcinoma in situ). Positive predictive values (PPV)
for detection of malignancy were calculated as recommended by the NHS breast screening programme. 5 The PPV for B3 diagnoses = (number of final The PPV for B4 diagnoses = (number of final malignant diagnoses / total number of subjects with B4 diagnosis excluding those without further histology) x 100%. Comparisons were made with a previous review of B3 and B4 NCB from July 1998 to June 2000. 7 In this study, we classified B3 and B4 diagnoses into entities similar to those that we previously used. 7, 12 Cases diagnosed as atypical intraductal epithelial proliferation (AIDEP) or suspicious of DCIS were subjected to histological review by 3 pathologists and classified into different entities according to the subtype of atypia. If a change in diagnosis was being considered, the slides were reviewed by a fourth pathologist. This review was blind to the final diagnosis.
Flat epithelial atypia was defined as dilated acini lined by up to a few layers of cells with round to oval nuclei and apical snouts. 13 The nuclei were typically small and evenly spaced. Occasionally the nuclei were larger with more obvious atypia. Atypical ductal hyperplasia is a diagnosis that strictly should be reserved for surgical specimens. Nevertheless, we used this term for proliferations of cells with small evenly spaced nuclei with solid, cribriform or micropapillary architecture. An important criterion was that low grade DCIS was being considered, but the changes were not sufficient for this diagnosis.
We follow the UK guidelines that diagnosis of low or intermediate grade DCIS The PPV for B3 lesions was 10%, significantly reduced from 25% in 1998 to 2000 (χ 2 = 9.5, P = 0.002). There were clear differences in outcome in the different B3 subtypes in both series. The PPV was highest for AIDEP (23%), but this was less than the figure of 41% in 1998 to 2000, although this difference was not significant (P = 0.12). The PPV for lobular neoplasia was much lower in the current series (0% versus 46%, χ 2 = 5.4, P = 0.02), but this does not take radiological-pathological discordance into account. Most of the other categories without epithelial atypia had low PPVs. The exceptions were spindle cell lesions (one of five was a spindle cell carcinoma) and mucocoelelike lesions (one of three was a mucinous carcinoma in a symptomatic patient), but the numbers in these categories are small. 11 of 16 (69%) cellular fibroepithelial lesions on NCB were phyllodes tumour on excision (8 benign, 3 borderline).
B4 cores
The most frequent B4 diagnosis in both series was 'suspicious of DCIS'. The The proportion of NCBs reported as B3 increased from 3.1% to 4.5%. A near doubling of the diagnosis of radial scar contributed to this. The most striking result was the decrease in the PPV for B3 diagnoses as a whole from 25% to 10% consistent with the reduction seen in a recent audit of Trent Breast screening NCB. 2 The increase in the diagnosis of radial scar was a contributory factor. This increase is likely to be the result of detection of more subtle lesions following the introduction of digital mammography and improvements in the resolution of ultrasound. Increasing use of vacuumassisted biopsies, yielding more tissue for diagnosis, may also have helped.
Most individual lesions had a similar PPV in both periods, but there was a dramatic reduction in the PPV for lobular neoplasia and a non-significant reduction for AIDEP. An important consideration in analysing the PPV for lobular neoplasia is whether the pathology explains the radiological and clinical features. Lobular neoplasia very rarely causes a mass. In a previous audit of lobular neoplasia on NCB from 1998 to 2006 we found that the majority of patients with malignancy identified in the surgical specimen had radiological-pathological discordance, particularly a mass that was not explained by the NCB histology. 18 Such discordances were more common in the earlier part of this previous study. 18 Improvements in localising the lesion by radiologists may explain this reduction in discordance. We therefore In agreement with previous studies, [7] [8] [9] 12, 15, 19 our results showed that AIDEP is one of the most frequent B3 lesions, and the PPV for detection of malignancy is about 30%. Similarly, in agreement with our previous study of screen detected B3 lesions in the Trent region 12 and with other authors, 20, 21 the results of the current study showed that when papillary lesions or radial scars are detected on NCB without associated epithelial atypia, the PPV for malignancy is low (7% and 3% respectively). Therefore, removal by vacuum 11 assisted biopsy appears to be a safe alternative to surgical excision if there is no associated epithelial atypia. 22 The high PPV of 33% for mucocoele-like lesions is most probably not an accurate assessment of the risk of malignancy associated with this lesion in view of the small sample. Four larger studies have found only one malignancy in 30 patients after a core biopsy showing a mucocole-like lesion without epithelial atypia. 12, 23 It is important to emphasise that the B3 category is not solely used for identifying lesions with an increased risk of epithelial malignancy. For example 69% of the lesions categorised as cellular fibroepithelial lesion on NCB were phyllodes tumour on excision, although none were malignant.
By contrast with the results for B3 NCBs, the proportion of NCBs reported as B4 showed a non-significant reduction from 1.1% to 0.8% and the PPV for a B4 diagnosis was similar in both periods (83% and 88%).
The review of cores with intraductal atypia showed a wide range of PPVs. All those categorised as suspicious of DCIS after review were malignant on excision. The numbers are low and in our previous audit the PPV was less than 100%. We therefore consider that repeat NCB or diagnostic surgical biopsy, rather than therapeutic excision, is still appropriate. The PPVs were recently recognised entity and the literature suggests that the risk for isolated flat epithelial atypia is low with PPVs varying between 0 and 20%. 13, [24] [25] [26] However, the risk on current evidence, is not sufficiently low for multidisciplinary discussion and diagnostic surgical biopsy to be safely avoided.
In conclusion, our results show a significant reduction in the PPV for B3 diagnoses as a group. The increase in the diagnosis of benign radial scar and the reduced PPV for lobular neoplasia contribute to this fall. The potential role of the reduction of the PPV of AIDEP is worthy of further investigation. The different categories of intraductal atypia showed a wide range of PPVs. The PPV for isolated flat epithelial atypia in the current series was not sufficiently low to avoid diagnostic surgical biopsy, but further larger studies would be useful to clarify this. This audit has not resulted in a change to our routine practice as the PPVs for individual lesions has not changed much apart from the reduction for lobular neoplasia. It would be interesting to know whether other centres have also seen a reduction in the PPV for B3 lesions and the reasons for any reduction. to have an increased risk of associated adjacent malignancy. 2, 5, 6 The B4 category is most commonly used for small fragments of atypical cells separate from the main core, focal atypical intraductal proliferations, which are insufficient for confident diagnosis of DCIS or very small foci of invasive carcinoma in which there is insufficient material for a definite diagnosis. 5, 7 Although the B3 and B4 categories constitute a relatively small proportion of all NCB, 2, 7-9 most cases progress to surgical intervention to establish an excision histology diagnosis.
MATERIALS AND METHODS
All NCBs reported as B3 or B4 in the 2-year period from January 2007 to December 2008 were studied. NCB results were categorised according to UK guidelines. 5 All patients with a core biopsy diagnosis are discussed at a multidisciplinary meeting, with a breast radiologist, histopathologist and surgeon present, at which decisions on further action are made. Those patients not undergoing an excision biopsy were therefore subject to multidisciplinary discussion to ensure that this conclusion was appropriate. for detection of malignancy were calculated as recommended by the NHS breast screening programme. 5 The PPV for B3 diagnoses = (number of final The PPV for B4 diagnoses = (number of final malignant diagnoses / total number of subjects with B4 diagnosis excluding those without further histology) x 100%. Comparisons were made with a previous review of B3 and B4 NCB from July 1998 to June 2000. 7 In this study, we classified B3 and B4 diagnoses into entities similar to those that we previously used. 7, 12 Cases diagnosed as atypical intraductal epithelial proliferation (AIDEP) or suspicious of DCIS were subjected to histological review by 3 pathologists and classified into different entities according to the subtype of atypia. If a change in diagnosis was being considered, the slides were reviewed by a fourth pathologist. This review was blind to the final diagnosis.
We follow the UK guidelines that diagnosis of low or intermediate grade DCIS
requires involvement of two duct spaces, whereas high grade DCIS can 
B4 cores
The most frequent B4 diagnosis in both series was 'suspicious of DCIS'. The 20% to 35% and PPVs for B4 lesions from 83% to 90%. 7, 9, 12, [14] [15] [16] [17] In a previous study of screen detected B3 lesions we noted a reduction in the PPV in recent years. 2 Therefore, in this study we compared B3 and B4 NCBs diagnosed in radiological-pathological discordance, particularly a mass that was not explained by the NCB histology. 18 Such discordances were more common in the earlier part of this previous study. 18 Improvements in localising the lesion by radiologists may explain this reduction in discordance. We therefore In agreement with previous studies, [7] [8] [9] 12, 15, 19 our results showed that AIDEP is one of the most frequent B3 lesions, and the PPV for detection of malignancy is about 30%. Similarly, in agreement with our previous study of screen detected B3 lesions in the Trent region 12 and with other authors, 20, 21 the results of the current study showed that when papillary lesions or radial scars are detected on NCB without associated epithelial atypia, the PPV for malignancy is low (7% and 3% respectively). Therefore, removal by vacuum It is important to emphasise that the B3 category is not solely used for identifying lesions with an increased risk of epithelial malignancy. For example 69% of the lesions categorised as cellular fibroepithelial lesion on NCB were phyllodes tumour on excision, although none were malignant.
In conclusion, our results show a significant reduction in the PPV for B3 diagnoses as a group. The increase in the diagnosis of benign radial scar and the reduced PPV for lobular neoplasia contribute to this fall. The potential role of the reduction of the PPV of AIDEP is worthy of further investigation. The different categories of intraductal atypia showed a wide range of PPVs. The PPV for isolated flat epithelial atypia in the current series was not sufficiently low to avoid diagnostic surgical biopsy, but further larger studies would be useful to clarify this. This audit has not resulted in a change to our routine practice as the PPVs for individual lesions has not changed much apart from the reduction for lobular neoplasia. It would be interesting to know whether other centres have also seen a reduction in the PPV for B3 lesions and the reasons for any reduction. 
